Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $281
Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $231 to $281.
Read original at benzingaStocks · News reference
Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $242
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $252 to $242.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 20, 2026, 12:47 PM
- Checked
- Jul 20, 2026, 12:47 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Top 3 Health Care Stocks That May Implode This Month
RSI warning: 3 overbought health care stocks could be flashing a real warning to investors with high momentum trading preferences
Read original at benzingaTenet Healthcare shares are trading higher after multiple analyst firms raised their respective price targets on the stock.
Read original at benzingaTruist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $290
Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $270 to $290.
Read original at benzinga